We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ibex Technologies Inc | TSXV:IBT | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.44 | 1.25 | 1.45 | 0 | 00:00:00 |
In order to comply with government decrees related to the COVID-19 pandemic and to mitigate risks to the health and safety of IBEX’s shareholders and employees, shareholders are asked not to attend the Meeting in person. In order to make the Meeting accessible to shareholders and others, IBEX will livestream the Meeting. To access the Meeting, please follow the instructions below:
Step 1: Log in online at:
https://ca1se.voxco.com/SE/?st=imZLd8veiGjZbfnvf%2FmRl59kW7%2B2YshJtPFf0ozxaqo%3D
Step 2: Complete the short survey to register for the Meeting.
Step 3: After registering, you will receive a confirmation email sent to the email address you provide in the survey. On the day before the Meeting, you will receive another confirmation email with access instructions for the Meeting.
IBEX shareholders are encouraged to vote prior to the Meeting by returning their proxy forms by 5:00 p.m. (eastern time) on January 18, 2021. Only registered shareholders and duly-appointed proxyholders will be entitled to vote at the Meeting.
ABOUT IBEX
IBEX manufactures and markets proteins for biomedical use through its wholly-owned subsidiary IBEX Pharmaceuticals Inc. (Montréal, QC). IBEX Pharmaceuticals also manufactures and markets a series of arthritis assays, which are widely used in osteoarthritis research.
For more information, please visit the Company’s website at www.ibex.ca.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
Paul BaehrPresident & CEOIBEX Technologies Inc.514-344-4004 x 143
1 Year Ibex Technologies Chart |
1 Month Ibex Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions